Kaplan–Meier plots for the Samsung cohort showed significant differences in overall survival (P = 0.0008 by log-rank test) between the two subgroups (Fig. 3b), strongly indicating that APOB ablation in HCC significantly influences clinical outcome and is associated with poor prognosis. The gene discussed is APOB; the disease is hepatocellular carcinoma.